hepatitis B

News

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV.

News

Gilead ordered to pay Merck & Co $2.54 bn by US court

Ruling relates to infringement of patents held by Merck subsidiary

News

Hepatitis Virus - 3d rendered illustration

European safety experts review latest hepatitis C drugs

European safety experts are reviewing the latest generation of hepatitis C drugs following cases of re-activation of hepatitis B in patients treated with the medicines, who had been infecte

Articles

Raising the bar: can Gilead’s next challenge be even bigger ...

How do you follow a genuine drug breakthrough, a cure for hepatitis C?

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

Gilead ordered to pay Merck & Co $2.54 bn by US court

European safety experts review latest hepatitis C drugs

Raising the bar: can Gilead’s next challenge be even bigger ...

Quartet of biotechs join Nasdaq after stellar IPOs

Discover a new era of healthcare panel engagement: Grounded ...

hepatitis B

Editor's Picks